- Home
- LYEL vs TVA Comparison
LYEL vs TVA Comparison
Compare LYEL & TVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$25.25
Company Overview
Basic Information| Metric | LYEL | TVA |
|---|---|---|
| Founded | 2018 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 369.4M | 303.9M |
| IPO Year | 2021 | 2025 |
Fundamental Metrics
Financial Performance| Metric | LYEL | TVA |
|---|---|---|
| Price | $25.25 | $10.54 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $16.67 | N/A |
| AVG Volume (30 Days) | 44.4K | ★ 79.7K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $41,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.65 | $9.98 |
| 52 Week High | $25.74 | $12.27 |
Technical Indicators
Market Signals| Indicator | LYEL | TVA |
|---|---|---|
| Relative Strength Index (RSI) | 69.41 | N/A |
| Support Level | $20.59 | N/A |
| Resistance Level | $25.20 | N/A |
| Average True Range (ATR) | 2.03 | 0.00 |
| MACD | 0.48 | 0.00 |
| Stochastic Oscillator | 95.62 | 0.00 |
Price Performance
Historical Comparison LYEL
TVA
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.
About TVA Texas Ventures Acquisition III Corp Class A Ordinary Share
Texas Ventures Acquisition III Corp is a blank check company.